{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:33:18Z","timestamp":1792812798473,"version":"4.5.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,28]]},"abstract":"<jats:p>This study aimed to evaluate Keratin 19 (KRT19) as a potential prognostic biomarker for the diagnosis and prognosis of pancreatic adenocarcinoma (PAAD). Using data from The Cancer Genome Atlas and the Gene Expression Omnibus, we analyzed KRT19 expression in PAAD tissues and identified differentially expressed genes associated with KRT19. Gene ontology (GO) and gene set enrichment analysis were performed to explore the underlying mechanisms of KRT19 in PAAD progression. Spearman correlation analysis was used to assess the relationships between KRT19 expression and immune cell infiltration, immune checkpoint genes, and TP53 expression. Logistic regression was employed to examine the association between KRT19 expression and clinicopathological features. Kaplan\u2013Meier survival curves, receiver operating characteristic curves, a nomogram model, and Cox regression analyses were used to evaluate the diagnostic and prognostic value of KRT19. KRT19 expression was significantly higher in tumor tissues than in adjacent non-tumor tissues and was closely associated with immune cell infiltration, HAVCR2 expression, and TP53 status. KRT19 levels correlated with T stage, overall survival (OS), disease-specific survival, and histologic grade. Cox regression and receiver operating characteristic analysis further indicated that KRT19 expression is an independent risk factor for OS, disease-specific survival, and progression-free interval in PAAD patients and can effectively distinguish tumor from normal tissue. In conclusion, the findings suggest that KRT19 could serve as a potential biomarker for the diagnosis and prognosis of PAAD, and it may be implicated in the regulation of the immune microenvironment.<\/jats:p>","DOI":"10.1097\/md.0000000000046233","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T14:01:13Z","timestamp":1764597673000},"page":"e46233","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Keratin 19 is a potential diagnostic and prognostic biomarker in pancreatic adenocarcinoma"],"prefix":"10.1097","volume":"104","author":[{"given":"Ling","family":"He","sequence":"first","affiliation":[{"name":"Department of Science and Education, People\u2019s Hospital of Fengjie, Fengjie, Chongqing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, People\u2019s Hospital of Fengjie, Fengjie, Chongqing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0725-812X","authenticated-orcid":false,"given":"Zhiqiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, People\u2019s Hospital of Fengjie, Fengjie, Chongqing, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260121","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer.","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"R2-20260121","doi-asserted-by":"crossref","first-page":"112940","DOI":"10.1016\/j.ejca.2023.112940","article-title":"Single-cell omics: a new perspective for early detection of pancreatic cancer?","volume":"190","author":"Wang","year":"2023","journal-title":"Eur J Cancer"},{"key":"R3-20260121","first-page":"212","article-title":"Cancer statistics in China, 2016.","volume":"45","author":"Zheng","year":"2023","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"R4-20260121","first-page":"7","article-title":"Cancer statistics, 2021.","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R5-20260121","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1158\/1078-0432.CCR-12-3295","article-title":"Regulation of cell proliferation and migration by keratin19-induced nuclear import of early growth response-1 in breast cancer cells.","volume":"19","author":"Ju","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R6-20260121","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/gutjnl-2012-304351","article-title":"Keratin 19: a key role player in the invasion of human hepatocellular carcinomas.","volume":"63","author":"Govaere","year":"2014","journal-title":"Gut"},{"key":"R7-20260121","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/onc.2016.221","article-title":"KRT19 directly interacts with beta-catenin\/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties.","volume":"36","author":"Saha","year":"2017","journal-title":"Oncogene"},{"key":"R8-20260121","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/gtmb.2019.0122","article-title":"Weighted gene co-expression network analysis reveals six hub genes involved in and tight junction function in pancreatic adenocarcinoma and their potential use in prognosis.","volume":"23","author":"Xia","year":"2019","journal-title":"Genet Test Mol Biomarkers"},{"key":"R9-20260121","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3934\/mbe.2020048","article-title":"Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.","volume":"17","author":"Li","year":"2019","journal-title":"Math Biosci Eng"},{"key":"R10-20260121","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"R11-20260121","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters.","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"R12-20260121","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"R13-20260121","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.3748\/wjg.v25.i46.6728","article-title":"Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer.","volume":"25","author":"Ou","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R14-20260121","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamaoncol.2019.0892","article-title":"Total neoadjuvant therapy with FOLFIRINOX in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical trial.","volume":"5","author":"Murphy","year":"2019","journal-title":"JAMA Oncol"},{"key":"R15-20260121","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejso.2006.10.004","article-title":"Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer.","volume":"33","author":"Goonetilleke","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"R16-20260121","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41419-025-07665-2","article-title":"The kinase domain of TRPM7 interacts with PAK1 and regulates pancreatic cancer cell epithelial-to-mesenchymal transition.","volume":"16","author":"Auwercx","year":"2025","journal-title":"Cell Death Dis"},{"key":"R17-20260121","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1038\/s41388-023-02775-7","article-title":"Pancreatic ductal adenocarcinoma induces neural injury that promotes a transcriptomic and functional repair signature by peripheral neuroglia.","volume":"42","author":"Weitz","year":"2023","journal-title":"Oncogene"},{"key":"R18-20260121","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.molimm.2013.05.242","article-title":"Activation of complement by monoclonal antibodies that target cell-associated beta(2)-microglobulin: implications for cancer immunotherapy.","volume":"56","author":"Pokrass","year":"2013","journal-title":"Mol Immunol"},{"key":"R19-20260121","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1084\/jem.20131625","article-title":"Fcgamma receptors enable anticancer action of proapoptotic and immune-modulatory antibodies.","volume":"210","author":"Kim","year":"2013","journal-title":"J Exp Med"},{"key":"R20-20260121","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1158\/1078-0432.CCR-15-2428","article-title":"Molecular pathways: targeting B7-H3 (CD276) for human cancer immunotherapy.","volume":"22","author":"Picarda","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R21-20260121","doi-asserted-by":"crossref","first-page":"e001823","DOI":"10.1136\/jitc-2020-001823","article-title":"Intratumoral CXCL13(+)CD8(+)T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma.","volume":"9","author":"Dai","year":"2021","journal-title":"J ImmunoTher Cancer"},{"key":"R22-20260121","doi-asserted-by":"crossref","first-page":"10791","DOI":"10.18632\/oncotarget.2505","article-title":"Induction of a specific CD8+ T-cell response to cancer\/testis antigens by demethylating pre-treatment against osteosarcoma.","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"key":"R23-20260121","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"R24-20260121","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/cancers13040821","article-title":"A palette of cytokines to measure anti-tumor efficacy of T cell-based therapeutics.","volume":"13","author":"Ramesh","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R25-20260121","first-page":"346","article-title":"B cells and IL-21-producing follicular helper T cells cooperate to determine the dynamic alterations of premetastatic tumor draining lymph nodes of breast cancer.","volume":"7","author":"Mao","year":"2024","journal-title":"Research (Wash D C)"},{"key":"R26-20260121","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1172\/JCI67428","article-title":"CD4(+) follicular helper T cell infiltration predicts breast cancer survival.","volume":"123","author":"Gu-Trantien","year":"2013","journal-title":"J Clin Invest"},{"key":"R27-20260121","doi-asserted-by":"crossref","first-page":"104972","DOI":"10.1016\/j.critrevonc.2025.104972","article-title":"From innate power to intelligent design: the evolution of NK cell-based cancer immunotherapy.","volume":"216","author":"Tuhin","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"R28-20260121","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.coph.2017.04.007","article-title":"Cancer cell and macrophage cross-talk in the tumor microenvironment.","volume":"35","author":"Dehne","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"R29-20260121","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3389\/fcell.2020.00758","article-title":"Tumor microenvironment in ovarian cancer: function and therapeutic strategy.","volume":"8","author":"Yang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R30-20260121","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.imlet.2015.05.018","article-title":"Challenges and future perspectives of T cell immunotherapy in cancer.","volume":"166","author":"de Aquino","year":"2015","journal-title":"Immunol Lett"},{"key":"R31-20260121","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/imm.12036","article-title":"The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells.","volume":"138","author":"Lindau","year":"2013","journal-title":"Immunology"},{"key":"R32-20260121","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/imr.12520","article-title":"Tim-3 and its role in regulating anti-tumor immunity.","volume":"276","author":"Das","year":"2017","journal-title":"Immunol Rev"},{"key":"R33-20260121","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.tranon.2018.07.012","article-title":"Immunogenomics analysis reveals that TP53 mutations inhibit tumor immunity in gastric cancer.","volume":"11","author":"Jiang","year":"2018","journal-title":"Transl Oncol"},{"key":"R34-20260121","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.csbj.2019.07.009","article-title":"Correlate the TP53 mutation and the HRAS mutation with immune signatures in head and neck squamous cell cancer.","volume":"17","author":"Lyu","year":"2019","journal-title":"Comput Struct Biotechnol J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:02:31Z","timestamp":1768993351000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":34,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046233","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"2025-07-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}